ONLINE LIBRARY

Articles and data focusing on covid ecmo and related issues

ECMO

Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases (Published Online: 20 March 2020) 

Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease indications, timing, and implementation
(Published Online: 28 February 2020)

Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation
(Published Online: 19 February 2020)

Coronavirus epidemic: preparing for extracorporeal organ support in intensive care (Published Online: 6 February 2020)

recent epidemiological publications and summaries

John Hopkins University Corona Virus Resource Center

Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis (Published : April 2020)

Persistence of Coronaviruses on Inanimate Surfaces and Their Inactivation With Biocidal Agents (Published Online: March 2020)

Association of Radiologic Findings With Mortality of Patients Infected With 2019 Novel Coronavirus in Wuhan, China
(Published Online: 19 March 2020)

Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures (Published Online: 19 March 2020)

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe COVID-19 (Published Online: 18 March 2020) 

COVID-19, an emerging coronavirus infection: Advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics (Published Online: 18 March 2020)

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (Published Online: 18 March 2020)

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
(Published Online: 18 March 2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial
(Published Online: 18 March 2020)

Hypothesis: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
(Published Online: 18 March 2020)

SARS-CoV-2 Infection in Children (Published Online: 18 March 2020)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (Published Online: 17 March 2020)

Coronavirus in pregnancy and delivery: Rapid review (Published Online: 17 March 2020)

Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China
(Published Online: 17 March 2020)

COVID-19: Consider cytokine storm syndromes and immunosuppression (Published Online: 16 March 2020)

COVID-19 – what should anaethesiologists and intensivists know about it? (Published Online: 16 March 2020)

2019 Novel Coronavirus Disease (COVID-19): Paving the Road for Rapid Detection and Point-of-Care Diagnostics
(Published Online: 14 March 2020)

Coronavirus Disease 2019 (COVID‐19): What we know? (Published Online: 14 March 2020)

COVID-19, ECMO, and lymphopenia: A word of caution (Published Online: 13 March 2020)

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China (Published Online: 13 March 2020)

The convalescent sera option for containing COVID-19 (Published Online: 13 March 2020)

Teicoplanin: An Alternative Drug for the Treatment of Coronavirus COVID-19? (Published Online: 13 March 2020)

COVID-19 induced Renin–Angiotensin System (RAS) imbalance may drive acute lung injury: The evidence and therapeutic options
(Published Online: 12 March 2020)

Arbidol Combined With LPV/r Versus LPV/r Alone Against Corona Virus Disease 2019: A Retrospective Cohort Study
(Published Online: 11 March 2020)

How to balance acute myocardial infarction and COVID-19: The protocols from Sichuan Provincial People’s Hospital
(Published Online: 11 March 2020)

Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential (Published Online: 10 March 2020)

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis (Published Online: 10 March 2020)

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
(Published Online: 9 March 2020)

Timely development of vaccines against SARS-CoV-2 (Published Online: 8 March 2020)

Arguments in favour of remdesivir for treating SARS-CoV-2 infections (Published Online: 6 March 2020)

SARS-CoV-2: A potential novel etiology of fulminant myocarditis (Published Online: 5 March 2020)

Guidelines for pregnant women with suspected SARS-CoV-2 infection (Published Online: 3 March 2020)

Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV
(Published Online: February 2020)

A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS coronavirus – A Possible Reference for Coronavirus disease-19 Treatment Option (Published Online: 27 February 2020)

COVID-19: Combining antiviral and anti-inflammatory treatments (Published Online: 27 February 2020)

Positive RT-PCR Test Results in Patients Recovered From COVID-19 (Published Online: 27 February 2020)

Non-invasive respiratory support for patients with novel coronavirus pneumonia clinical efficacy and reduction in risk of infection transmission (Published Online: 24 February 2020)

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection (Published Online: 20 February 2020)

An interactive web-based dashboard to track COVID-19 in real time (Published Online: 19 February 2020)

Virus against virus: A potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses (Published Online: 18 February 2020)

Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines (Published Online: 13 February 2020)

Therapeutic options for the 2019 novel coronavirus (2019-nCoV) (Published Online: 10 February 2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Published Online: 4 February 2020)

Potent Binding of 2019 Novel Coronavirus Spike Protein by a SARS Coronavirus-Specific Human Monoclonal Antibody
(Published Online: 27 January 2020)

Global research on coronavirus disease (COVID-19) and Database of publications on coronavirus disease (COVID-19)

Professional and Home-Made Face Masks Reduce Exposure to Respiratory Infections among the General Population
(Published Online: 9 July 2008)

diagnosis

Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia? (Published Online: 13 March 2020)

A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias. (Published Online: 12 March 2020)

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis (Published Online: 3 March 2020)

CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China. (Published Online: 19 February 2020)

pathophysiology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein (Published Online: 19 March 2020)

Dysregulation of immune response in patients with COVID-19 in Wuhan, China. (Published Online: 12 March 2020)

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection (Published Online: 8  February 2020)

prevention

Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak –Lessons from Taiwan’s SARS response.
(Published Online: 12 March 2020)

pediatrics

SARS-CoV-2 Infection in Children. (Published Online: 18 March 2020)

Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. (Published Online: 12 March 2020)

pregnancy

Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. (Published Online: 27 February 2020)

treatment strategies

Soluble angiotensin-converting enzyme 2: A potential approach for coronavirus infection therapy? (Published Online: 13 March 2020)

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Published Online: 9 March 2020)

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor (Published Online: 5 March 2020)

Angiotensin receptor blockers as tentative SARS‐CoV‐2 therapeutics (Published Online: 4 March 2020)

Remdesivir: A Promising Antiviral Against Coronaviruses (Published Online: 3 March 2020)

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19  (Published Online: 28 February 2020)

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. (Published Online: 6 February 2020)

Discovering drugs to treat coronavirus disease 2019 (COVID-19). (Published Online: 2020)

Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)

cardiovascular flashlight

Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin.

In cooperation with Tereza Radl and CZECH HEALTH INTERACTIVE, s.r.o.

EuroElso